Featured Abstracts

Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn

Faecal calprotectin is a very reliable tool to predict and monitor the risk of relapse after therapeutic de-escalation in patients with inflammatory bowel diseases

Systematic review and meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn

Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region

Events Within the First Year of Life, but not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases

Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory BowelDisease Patients

Erectile Dysfunction Is Highly Prevalent in Men With Newly Diagnosed Inflammatory Bowel Disease

Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis

Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know

Ultrasound vs Endoscopy, Surgery, or Pathology for the Diagnosis of Small BowelCrohn

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

Risk of Infection and Types of Infection Among Elderly Patients With InflammatoryBowel Disease: A Retrospective Database Analysis

Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort

Emerging roles of bile acids in mucosal immunity and inflammation

Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial

Diagnosis and treatment of dermatologic diseases in inflammatory bowel disease

Dynamics of metatranscription in the inflammatory bowel disease gut microbiome

Exercise in patients with inflammatory bowel diseases: current perspectives

Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease

Rescue Diverting Loop Ileostomy: An Alternative to Emergent Colectomy in the Setting of Severe Acute Refractory IBD-Colitis

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-?-Directed Therapy for InflammatoryBowel Disease

Inflammatory Bowel Disease Is Not a Contraindication for Bariatric Surgery

Predicting and explaining inflammation in Crohn's disease patients using predictive analytics methods and electronic medical record data

Featured Abstracts

Elimination Diets for Irritable Bowel Syndrome: Approaching the End of the Beginning

Overlapping irritable bowel syndrome and inflammatory bowel disease

Risk factors for upper and lower functional gastrointestinal disorders in Persian Gulf War Veterans during and post-deployment

Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis

Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome

SKYPE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME: Effectiveness and Comparison with Face-to-Face Treatment

Integrating psychosocial approaches into the management of childhood functional gastrointestinal disorders: a role for social work

Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia

Prucalopride for the treatment of constipation: a view from 2015 and beyond

Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy

Irritable Bowel Syndrome and Dietary Interventions

Gut Microbiota in Patients With Irritable Bowel Syndrome-a Systematic Review

Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide

Number of retained radiopaque markers on a colonic transit study does not correlate with symptom severity or quality of life in chronic constipation

Wake-up Call to Clinicians: The Impact of Sleep Dysfunction on Gastrointestinal Health and Disease

The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report

© Copyright 2013-2019 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.